Following initial treatment for thyroid cancer (surgery), patients are then given Radioactive Iodine Ablation Treatment. Generally a high thyroid stimulating hormone (TSH) level is required in both treatment and follow-up of thyroid cancer. Traditionally patients reduced and then ceased their dose of thyroxine (Oroxine/Eutroxsig) before this treatment. An alternate approach to stopping thyroxine therapy is to give the patient Thyrogen. (Thyrogen rh TSH (Man Made Recombinant Human Thyroid Stimulating Hormone))
Radioactive Iodine Treatment (RAI) is usually recommended for patients who have been diganosed with thyroid cancer and have recently had a total thyroidectomy to remove the cancer.
Lenvatinib - Differentiated Thyroid Cancer Treatment
Nexavar is used to treat thyroid cancer (differentiated thyroid carcinoma). Nexavar is a multi-kinase inhibitor. It works by slowing down the rate of growth of cancer cells and cutting off the blood supply that keeps cancer cells growing.
Surgery - Semi Thyroidectomy - Total Thyroidectomy
An Endocrine Surgeon is the specialist who performs a thyroidectomy. A total thyroidectomy is recommended for thyroid cancer, restriction caused by an enlarged thyroid gland pressing on the windpipe, oesophagus or nerves. Surgery is also performed when a patient has a suspicious nodule(s), which could be malignant or an uncontrollable overactive thyroid gland.
Your treating thyroid specialist will prescribe a dose of Neo-Mercazole or PTU to treat your condition and will monitor your thyroid response through pathology tests.
Phone: +61 (0) 447 834 724 (If you would like to organise a phone chat, please email to organise a time, thank you!)
Mailing Address: PO Box 7161, Norwest NSW 2153, Australia
OUR MISSION
The mission of The Australian Thyroid Foundation Ltd (ATF) is to offer support, information and education to members and their families through the many services provided by The ATF and raise awareness about health consequences of iodine deficiency and the benefits of good thyroid health.